Correlation Between HLS Therapeutics and Crescita Therapeutics
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Crescita Therapeutics, you can compare the effects of market volatilities on HLS Therapeutics and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Crescita Therapeutics.
Diversification Opportunities for HLS Therapeutics and Crescita Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between HLS and Crescita is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Crescita Therapeutics go up and down completely randomly.
Pair Corralation between HLS Therapeutics and Crescita Therapeutics
Assuming the 90 days horizon HLS Therapeutics is expected to under-perform the Crescita Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, HLS Therapeutics is 14.76 times less risky than Crescita Therapeutics. The pink sheet trades about -0.03 of its potential returns per unit of risk. The Crescita Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 53.00 in Crescita Therapeutics on August 26, 2024 and sell it today you would lose (8.00) from holding Crescita Therapeutics or give up 15.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
HLS Therapeutics vs. Crescita Therapeutics
Performance |
| Timeline |
| HLS Therapeutics |
| Crescita Therapeutics |
HLS Therapeutics and Crescita Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HLS Therapeutics and Crescita Therapeutics
The main advantage of trading using opposite HLS Therapeutics and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.| HLS Therapeutics vs. Aion Therapeutic | HLS Therapeutics vs. Cannara Biotech | HLS Therapeutics vs. Knight Therapeutics | HLS Therapeutics vs. Canntab Therapeutics Limited |
| Crescita Therapeutics vs. Amexdrug | Crescita Therapeutics vs. The BC Bud | Crescita Therapeutics vs. Antisense Therapeutics Limited | Crescita Therapeutics vs. Cannara Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |